IP Library Granted Patent US 10,420,857
Granted Patent B2
US 10,420,857 · App. 15/444,463 · Granted Sep 24, 2019

High density fibrous polymers suitable for implant

Inventors: Timothy A Ringeisen (Exton, PA); William Christopher Wattengel (Exton, PA)
Assignee: DSM IP ASSETS, B.V.
A61L27/16A61B17/68A61B17/70A61B17/72A61F2/0059A61F2/24A61F2/28A61F2/30756A61F2/44A61L26/008A61L26/0033A61L27/12A61L27/18A61L27/20A61L27/225A61L27/227A61L27/24A61L27/26A61L27/3616A61L27/3804A61L27/3834A61L27/46A61L27/48A61L27/52A61L27/54A61L27/56A61L27/58C08H1/06C08L5/04C08L5/08C08L67/04C08L89/06A61B17/7062A61B2017/00526A61F2/3094A61F2/4241A61F2/4465A61F2002/30062A61F2002/4475A61F2002/4495A61F2210/0004A61F2310/00365A61L2300/112C08K3/013C08L2205/16
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,420,857
App. No.
15/444,463
Granted
Sep 24, 2019
Kind
B2
Abstract

This invention includes malleable, biodegradable, fibrous compositions for application to a tissue site in order to promote or facilitate new tissue growth. One aspect of this invention is a fibrous component that provides unique mechanical and physical properties. The invention may be created by providing a vessel containing a slurry, said slurry comprising a plurality of natural or synthetic polymer fibers and at least one suspension fluid, wherein the polymer fibers are substantially evenly dispersed and randomly oriented throughout the volume of the suspension fluid; applying a force, e.g., centrifugal, to said vessel containing said slurry, whereupon said force serves to cause said polymer fibers to migrate through the suspension fluid and amass at a furthest extent of the vessel, forming a polymer material, with said polymer material comprising polymer fibers of sufficient length and sufficiently viscous, interlaced, or interlocked to retard dissociation of said polymer fibers.

Claims (21)

1. A composition suitable for implantation into a living being, comprising a network of randomly interlocked polymer fibers, wherein said polymer fibers are arranged with respect to a particulate to maintain said particulate within a spatial conformation within the composition, and retard disassociation of the particulate from the composition, wherein the network of randomly interlocked polymer fibers is configured to be combined with a fluid.

2. The composition of claim 1 , wherein said polymer fibers are arranged to support, confine or lock said particulate within said spatial conformation and retard disassociation of said particulate from said composition.

3. The composition of claim 1 wherein the network of randomly interlocked polymer fibers is initially in a dry form, and upon being combined with said fluid, results in a rehydrated implantable composition, wherein the fluid is selected from at least one of blood, bone marrow aspirates, stem cells, or concentrates thereof.

4. The composition of claim 3 , whereupon said particulate is kneaded into the rehydrated implantable composition prior to implantation.

5. The composition of claim 1 wherein at least a portion of said polymer is at least one biopolymer selected from the group consisting of collagen, chitosan, alginate, hyaluronic acid, poly-lactic acid, poly-glycolic acid, poly-caprolactone, and polyurethane.

6. The composition of claim 1 , further comprising at least one of a biologically active agent or a lubricant.

7. The composition of claim 1 , wherein said particulate comprises at least one of a biologically active gent, a microsphere or a microcapsule.

8. The composition of claim 1 , wherein said particulate comprises a plurality of pores.

9. The composition of claim 8 , wherein said polymer fibers are arranged in such a manner so as to be at least partially interlaced within said pores of the particulate.

10. The composition of claim 1 , wherein said particulate is at least one of ceramic, glass, glass-ceramic, metals, tricalcium phosphate, hydroxylapatite, calcium sulfate, autologous bone graft, allograft bone matrix, demineralized bone, polymers, microspheres, microcapsules, hyaluronic acid, collagen, chitosan, alginate, poly-lactic acid, poly-glycolic acid, poly-caprolactone, polyurethane or combinations thereof.

11. The composition of claim 1 , further comprising a second polymer, said second polymer being soluble, and wherein said polymer fibers are surrounded by said second polymer.

12. The composition of claim 11 , wherein said second polymer is arranged to provide lubrication for said polymers fibers, whereupon said composition becomes partially de-interlocked and shapeable.

13. The composition of claim 1 , wherein the composition is arranged in the shape of a brick, a plate, a disk, an ellipse, a sheet, a membrane, a wedge, a pin, a rod, a cylinder, a roll, a tube, a cup, a sphere, a semi-sphere, a cone, a pyramid, a frustum of a cone, a frustum of a wedge, or a frustum of a pyramid.

14. The composition of claim 1 , wherein said polymer fibers are partially de-interlocked, whereupon said composition becomes shapeable.

15. The composition of claim 1 , wherein said polymer fibers are cross-linked.

16. The composition of claim 1 , further comprising a mesh or a screen.

17. A kit comprising a) a centrifuge, and b) a composition comprising a plurality of polymer fibers, wherein said polymer fibers are of sufficient quantity and sufficiently interlaced or interlocked as to retard dissociation of individual polymer fibers upon implantation.

18. The kit of claim 17 , wherein said composition comprises a dry network of randomly interlocked polymer fibers, and at least one particulate, wherein said polymer fibers are arranged with respect to a particulate to maintain said particulate within a spatial conformation within the composition, and retard disassociation of the particulate from the composition, wherein the network of randomly interlocked polymer fibers is configured to be combined with a fluid.

19. The kit of claim 17 , wherein said centrifuge is configured to create a concentrate from a sample placed within the centrifuge, wherein said sample comprises blood or bone marrow.

20. The kit of claim 17 , wherein said composition is positioned within the centrifuge prior to the concentration occurring.

21. The kit of claim 19 , wherein said concentrate further comprises a biologically active agent.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 21, 2019
From: RINGEISEN, TIMOTHY A.; WATTENGEL, W. CHRISTIAN
To: KENSEY NASH CORPORATION
Reel/Frame 048661/0780 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 21, 2019
From: KENSEY NASH CORPORATION
To: KENSEY NASH HOLDING CORPORATION
Reel/Frame 048661/0987 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 21, 2019
From: KENSEY NASH HOLDING CORPORATION
To: KENSEY NASH BVF TECHNOLOGY, LLC
Reel/Frame 048662/0045 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 21, 2017
From: KENSEY NASH BVF
To: DSM IP ASSETS B.V.
Reel/Frame 043343/0159 →
Continuity (8)
Continuation 14159427 · Jan 20, 2014
Continuation 13481575 · May 25, 2012
Continuation 13027025 · Feb 14, 2011
Division 11741611 · Apr 27, 2007
Continuation 11178175 · Jul 8, 2005
Continuation PCTUS2004019805 · Jun 19, 2004
Continuation In Part 10601216 · Jun 20, 2003
Related Publication 20170203007A1 · Jul 20, 2017
Cited By (2)
US 12,214,046 US 12,232,963